Zagotenemab (MAPT) - Research Grade Biosimilar
Product Specifications
Background
Zagotenemab is an antibody drug that targets TAU protein, and has started Phase II clinical trial in April 2018.
Immunogen
Humanized / MAPT [Homo sapiens]
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Neuroscience
Purification
>95%
Concentration
Batch dependent
Buffer
PBS buffer pH7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.
Product Datasheet
https://www.prosci-inc.com/?datasheet_sku=11-008
Fragment
IgG4-kappa
NCBI Organism
Homo sapiens
Other Product Names
LY-3303560
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
